Product NDC: | 0143-9679 |
Proprietary Name: | Glycopyrrolate |
Non Proprietary Name: | Glycopyrrolate |
Active Ingredient(s): | .2 mg/mL & nbsp; Glycopyrrolate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0143-9679 |
Labeler Name: | West-Ward Pharmaceutical Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090963 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110921 |
Package NDC: | 0143-9679-10 |
Package Description: | 10 VIAL in 1 CARTON (0143-9679-10) > 20 mL in 1 VIAL (0143-9679-01) |
NDC Code | 0143-9679-10 |
Proprietary Name | Glycopyrrolate |
Package Description | 10 VIAL in 1 CARTON (0143-9679-10) > 20 mL in 1 VIAL (0143-9679-01) |
Product NDC | 0143-9679 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Glycopyrrolate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110921 |
Marketing Category Name | ANDA |
Labeler Name | West-Ward Pharmaceutical Corp |
Substance Name | GLYCOPYRROLATE |
Strength Number | .2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |